Deregulation of the Rb and p53 pathways in uveal melanoma

被引:85
|
作者
Brantley, MA
Harbour, JW
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Div Mol Oncol, St Louis, MO 63110 USA
来源
AMERICAN JOURNAL OF PATHOLOGY | 2000年 / 157卷 / 06期
关键词
D O I
10.1016/S0002-9440(10)64817-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Uveal melanoma is the most common primary eye cancer, yet its molecular pathogenesis is poorly understood. In this study, we investigated the immunohistochemical expression of proteins in the Rb and p53 tumor suppressor pathways in 33 uveal melanomas from enucleated eyes. Strong nuclear staining for Rb was present in most tumors. However, a few cases displayed weak nuclear staining and strong cytoplasmic staining (possibly indicating Rb mutation), and this aberrant staining correlated strongly with failed radiotherapy or thermotherapy before enucleation. Staining for cyclin D1 was positive in most tumors and was associated with advanced age and larger tumor size, which are both poor prognostic factors. Generally, immunostaining for p53 was weak (suggesting a lack of p53 mutations), although p53 positivity correlated strongly with staining for phosphorylated Rb, supporting the notion that inappropriate phosphorylation of Rb can induce p53, Strong immunostaining for MDM2, which can functionally block p53 activity, was observed in most tumors and correlated significantly with female sex. Strong cytoplasmic staining was observed for Bc12, which can inhibit both p53-dependent and -independent apoptosis, We conclude that Rb and p53 are mutated infrequently in uveal melanoma, but their respective pathways may be functionally inactivated.
引用
收藏
页码:1795 / 1801
页数:7
相关论文
共 50 条
  • [31] PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
    L Davies
    D Spiller
    M R H White
    I Grierson
    L Paraoan
    Cell Death & Disease, 2011, 2 : e136 - e136
  • [32] Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines
    McDoniels-Silvers, AL
    Herzog, CR
    Tyson, FL
    Malkinson, AM
    You, M
    EXPERIMENTAL LUNG RESEARCH, 2001, 27 (03) : 297 - 318
  • [33] PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells
    Davies, L.
    Spiller, D.
    White, M. R. H.
    Grierson, I.
    Paraoan, L.
    CELL DEATH & DISEASE, 2011, 2 : e136 - e136
  • [34] Alterations of p53 and Rb Pathways Are Associated with High Proliferation in Bladder Urothelial Carcinomas
    Goussia, Anna C.
    Papoudou-Bai, Alexandra
    Charchanti, Antonia
    Kitsoulis, Panagiotis
    Kanavaros, Panagiotis
    Kalef-Ezra, John
    Stefanou, Dimitrios
    Agnantis, Niki J.
    ANTICANCER RESEARCH, 2018, 38 (07) : 3985 - 3988
  • [35] Mitogenic signaling and the RB/p53 network
    Sherr, Charles J.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [36] EXPRESSION OF MUTANT P53 IN MELANOMA
    STRETCH, JR
    GATTER, KC
    RALFKIAER, E
    LANE, DP
    HARRIS, AL
    CANCER RESEARCH, 1991, 51 (21) : 5976 - 5979
  • [37] Role of p53 and Rb in ovarian cancer
    Corney, David C.
    Flesken-Nikitin, Andrea
    Choi, Jinhyang
    Nikitin, Alexander Yu.
    OVARIAN CANCER: STATE OF THE ART AND FUTURE DIRECTIONS IN TRANSLATIONAL RESEARCH, 2008, 622 : 99 - 117
  • [38] Cancer therapy based on p53 and Rb
    Korn, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S116 - S116
  • [39] P53 AND RB, CLINICAL AND THERAPEUTIC PERSPECTIVES
    SOUSSI, T
    DEFROMENTEL, CC
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 25 - 26
  • [40] TUMOR BIOLOGY - P53, GUARDIAN OF RB
    WHITE, E
    NATURE, 1994, 371 (6492) : 21 - 22